Atlas Trials

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

Clinical trial NCT00653588 · COMPLETED

Trial details

NCT number
NCT00653588
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HypercholesterolemiaCoronary Heart Disease
Start date
2003-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.